Europe’s medical devices industry saw a flat growth in deal activity during April 2021, when compared with the last 12-month average, led by $5bn acquisition of CA Healthcare Acquisition and LumiraDx , according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 34 medical devices industry deals worth $6.3bn were announced for the region in April 2021, against the 12-month average of 34 deals.

Of all the deal types, venture financing saw most activity in April 2021 with 18 transactions, representing a 52.9% share for the region.

In second place was M&A with 13 deals, followed by private equity deals with three transactions, respectively capturing a 38.2% and 8.8% share of the overall deal activity for the month.

In terms of value of deals, M&A was the leading category in Europe’s medical devices industry with $6.08bn, followed by venture financing deals totalled $245.8m.

Europe medical devices industry deals in April 2021: Top deals

The top five medical devices deals accounted for 97.7% of the overall value during April 2021.

The combined value of the top five medical devices deals stood at $6.18bn, against the overall value of $6.3bn recorded for the month.

The top five medical devices industry deals of April 2021 tracked by GlobalData were:

1) The $5bn merger of CA Healthcare Acquisition and LumiraDx

2) The $795m acquisition deal with Mobidiag by Hologic

3) AddLife ’s $216.53m acquisition of Vision Ophthalmology Group

4) The $115m venture financing of CeQur by Credit Suisse Entrepreneur Capital , Endeavour Vision , Federated Hermes Kaufmann Fund , GMS Capital , Kingdon Capital Management, SchroderBank AG, Tandem Diabetes Care , VI Partners and Ypsomed

5) Cambridge Innovation Capital , Earlybird Venture Capital GmbHKG, Jonathan Milner, Koch Disruptive Technologies and Mercia Asset Management ’s venture financing of Sense Biodetection for $50m.